US Trial Finds Drug Cuts Coronavirus Mortality 40%

[ducks]

Preliminary findings released Tuesday for a U.S.-based clinical trial of anti-parasite drug ivermectin found that the mortality rate for coronavirus patients fell 40%, according to the Medrxiv.org site.
The ivermectin study -- it began in March as part of a larger Australian-led clinical study -- focused on 280 patients, 173 of whom were treated with the drug at four Broward County, Florida, hospitals.

The research team was led by Dr. Jean-Jacques Rajter, a Broward Health Medical Center physician, and his wife, Juliana Cepelowicz Rajter.

[SnakeBoy]

It's available at tractor supply in oral, injectable, and pour on formulations.

Use the pour on if you get lice or mites with your Covid-19

[boutons_deux]

The approved dose of ivermectin alone not useful in treating COVID-19

A new paper published on the preprint server medRxiv (https://www.medrxiv.org/content/10.1101/2020.04.21.20073262v1) in April 2020 shows that

the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

is not feasible.

This contradicts earlier reports (https://www.news-medical.net/news/20200406/Antiparasitic-drug-Ivermectin-kills-coronavirus-in-48-hours.aspx) of its ability to suppress the virus in vitro.

https://www.news-medical.net/news/20200427/Ivermectin-alone-not-useful-in-treating-COVID-19.aspx